Daeryun Law Firm and Medicos Biotech MOU for ‘Biohealth Global Market Legal Support’
Daeryun Law Firm announced on the 17th that it has signed an MOU with Medicos Biotech, a biomaterial developer, for legal stability in the bio industry and entry into the global market. Daeryun Law Firm signed an MOU with Medicos Biotech, a biomaterial developer, for legal stability in the bio and beauty industry and entry into the global market. At the signing ceremony held at Daeryun's Seoul office on the 11th, Daeryun CEO Kim Kuk-il, attorney Son Dong-hu, and Daeryun's U.S. attorney Kyle Courtnall, Tal. Hirshberg attended, and CEO Kim Soon-cheol of Medicos Biotech was present. Medicos Biotech Co., Ltd. is a specialized company that develops functional biomaterials and possesses stem cell and immune cell-based source technology, and has accumulated global-level R&D capabilities in various fields such as anti-aging, immune enhancement, and skin regeneration. In particular, we are continuously expanding our export base centered on the Asian and North American markets based on medical beauty, functional health functional foods, and pharmaceutical-bio convergence solutions, and recently, we are entering the global health tech market in earnest through the development of a customized healthcare platform based on precision medicine technology and AI analysis. Daeryun Law Firm provides a variety of legal advice, including medical dispute mediation, administrative litigation, new medical technology evaluation, and non-face-to-face treatment, focusing on the medical pharmaceutical group, which has many lawyers with doctor and pharmacist qualifications. In particular, bio startups often have difficulty obtaining advice necessary for business operations such as law, labor, tax, and accounting, but Daeryun is supporting bio startups in various ways through a total program. Through this MOU, the two organizations provide ▲ legal risk diagnosis and advice related to functional bio materials and medical beauty technology, ▲ consulting on establishing a bio data and personal information protection system and response to international regulations, and ▲ consulting on overseas licensing strategies such as the FDA and EMA. We plan to promote domestic and international integrated cooperation tasks such as linking with the global partnership network, ▲ raising global legal awareness and policy proposals in the biohealth field by holding joint seminars and forums, and ▲ providing labor, tax, and accounting advice necessary for business operation. Kim Soon-cheol, CEO of Medicos Biotech, said, “Commercialization of biotechnology must be achieved not only with scientific evidence, but also with securing legal credibility that meets international standards.” “We will push for commercialization more firmly,” said Kim Kuk-il, CEO of Daeryun Law Firm. “Legal risk management in the global market is key in the bio industry due to regulatory differences between countries and complex licensing procedures,” and “Daeryun will work with us as a strategic partner beyond legal partnership to ensure that Medicos Biotech’s innovative capabilities achieve stable and sustainable growth at home and abroad.” Reporter Son Dong-wook, Law Leader, twson@lawleader.co.kr
Daeryun Law Firm and Medicos Biotech MOU for ‘Biohealth Global Market Legal Support’ (Click here)